Cargando…
In vivo surveillance and elimination of teratoma‐forming human embryonic stem cells with monoclonal antibody 2448 targeting annexin A2
This study describes the use of a previously reported chimerised monoclonal antibody (mAb), ch2448, to kill human embryonic stem cells (hESCs) in vivo and prevent or delay the formation of teratomas. ch2448 was raised against hESCs and was previously shown to effectively kill ovarian and breast canc...
Autores principales: | Tan, Heng Liang, Tan, Bao Zhu, Goh, Winfred Xi Tai, Cua, Simeon, Choo, Andre |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6790577/ https://www.ncbi.nlm.nih.gov/pubmed/31388993 http://dx.doi.org/10.1002/bit.27135 |
Ejemplares similares
-
Targeting of embryonic annexin A2 expressed on ovarian and breast cancer by the novel monoclonal antibody 2448
por: Cua, Simeon, et al.
Publicado: (2018) -
Preclinical Activity of Embryonic Annexin A2-Specific Chimeric Antigen Receptor T Cells Against Ovarian Cancer
por: Leong, Leonard, et al.
Publicado: (2020) -
2448. Emergence of Candida auris in a Delaware Healthcare System
por: Pheiffer, Rebecca, et al.
Publicado: (2023) -
Conservation of oncofetal antigens on human embryonic stem cells enables discovery of monoclonal antibodies against cancer
por: Tan, Heng Liang, et al.
Publicado: (2018) -
2448 The effect of allopurinol on pediatric patients undergoing maintenance chemotherapy for acute lymphoblastic leukemia or lymphoblastic lymphoma
por: Bhuiyan, Mariam M., et al.
Publicado: (2018)